ATE453617T1 - Substituierte n-arylbenzamide und verwandte verbindungen zur behandlung von amyloidkrankheiten und synukleinopathien - Google Patents

Substituierte n-arylbenzamide und verwandte verbindungen zur behandlung von amyloidkrankheiten und synukleinopathien

Info

Publication number
ATE453617T1
ATE453617T1 AT05749770T AT05749770T ATE453617T1 AT E453617 T1 ATE453617 T1 AT E453617T1 AT 05749770 T AT05749770 T AT 05749770T AT 05749770 T AT05749770 T AT 05749770T AT E453617 T1 ATE453617 T1 AT E453617T1
Authority
AT
Austria
Prior art keywords
treatment
synucleinopathies
substituted
related compounds
arylbenzamide
Prior art date
Application number
AT05749770T
Other languages
English (en)
Inventor
Alan Snow
Beth Nguyen
Thomas Lake
Gerardo Castillo
Manfred Weigele
Original Assignee
Proteotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteotech Inc filed Critical Proteotech Inc
Application granted granted Critical
Publication of ATE453617T1 publication Critical patent/ATE453617T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05749770T 2004-05-12 2005-05-12 Substituierte n-arylbenzamide und verwandte verbindungen zur behandlung von amyloidkrankheiten und synukleinopathien ATE453617T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57066904P 2004-05-12 2004-05-12
US62952504P 2004-11-18 2004-11-18
PCT/US2005/016677 WO2005113489A1 (en) 2004-05-12 2005-05-12 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies

Publications (1)

Publication Number Publication Date
ATE453617T1 true ATE453617T1 (de) 2010-01-15

Family

ID=34969702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05749770T ATE453617T1 (de) 2004-05-12 2005-05-12 Substituierte n-arylbenzamide und verwandte verbindungen zur behandlung von amyloidkrankheiten und synukleinopathien

Country Status (18)

Country Link
US (2) US7745490B2 (de)
EP (1) EP1751097B1 (de)
JP (1) JP5203701B2 (de)
KR (1) KR101168451B1 (de)
AT (1) ATE453617T1 (de)
AU (1) AU2005245412B2 (de)
BR (1) BRPI0510803A (de)
CA (1) CA2566090C (de)
DE (1) DE602005018634D1 (de)
DK (1) DK1751097T3 (de)
ES (1) ES2337162T3 (de)
IL (1) IL179160A (de)
MX (1) MXPA06012603A (de)
NO (1) NO20065717L (de)
NZ (1) NZ551589A (de)
RU (1) RU2381213C2 (de)
SG (1) SG137850A1 (de)
WO (1) WO2005113489A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090124690A1 (en) * 2000-04-03 2009-05-14 Alberte Randall S Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins
US20070208087A1 (en) * 2001-11-02 2007-09-06 Sanders Virginia J Compounds, compositions and methods for the treatment of inflammatory diseases
CN101460161A (zh) * 2006-03-29 2009-06-17 弗尔德里克斯制药股份有限公司 α-突触核蛋白毒性的抑制
WO2009111611A2 (en) * 2008-03-05 2009-09-11 Proteotech Inc. Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
EP2098226A1 (de) * 2008-03-06 2009-09-09 Forschungsverbund Berlin e.V. AKAP-PKA-Interaktionshemmer zur Anwendung in der Behandlung von Herzkrankheiten
US20130109714A1 (en) * 2010-03-26 2013-05-02 National University Corporation Hokkaido University Neurodegenerative disease therapeutic agent
US20120251448A1 (en) * 2011-03-03 2012-10-04 Hefti Franz F Compounds for Use in the Detection of Neurodegenerative Diseases
CN111315735B (zh) 2017-09-04 2024-03-08 C4医药公司 二氢苯并咪唑酮
US10799551B2 (en) 2017-09-25 2020-10-13 Amorepacific Corporation Composition for enhancing cognitive function comprising green tea extract which has modified amounts of ingredients
KR102011033B1 (ko) * 2017-09-25 2019-08-14 (주)아모레퍼시픽 성분 함량이 변화된 녹차 추출물을 포함하는 인지기능 개선용 조성물
US20220041591A1 (en) * 2018-10-19 2022-02-10 Auckland Uniservices Limited Compounds for treating diabetes and/or related conditions
WO2020181232A1 (en) 2019-03-06 2020-09-10 C4 Therapeutics, Inc. Heterocyclic compounds for medical treatment
WO2023224893A1 (en) * 2022-05-20 2023-11-23 Merck Sharp & Dohme Llc Inhibitors of msba as antibiotics, pharmaceutical compositions, and uses thereof
CN117682973A (zh) * 2022-09-26 2024-03-12 中国药科大学 磺酰胺类化合物及其医药用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5916871A (ja) * 1982-07-20 1984-01-28 Shionogi & Co Ltd スルホンアミド系ベンズアミド類
JPS63132237A (ja) * 1986-11-21 1988-06-04 Konica Corp 迅速処理を行なつても優れた発色性を有するハロゲン化銀写真感光材料
MX9203460A (es) * 1988-09-12 1992-09-01 Upjohn Co Nuevos analogos cc-1065 que tienen dos subunidades cpi.
GB8914660D0 (en) * 1989-06-26 1989-08-16 Fujisawa Pharmaceutical Co Aniline derivatives,processes for production thereof and pharmaceutical compositions comprising the same
JPH04285955A (ja) * 1991-03-14 1992-10-12 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
AU754943B2 (en) * 1998-05-22 2002-11-28 Avanir Pharmaceuticals Benzimidazole analogs as down-regulators of IgE
AP2001002103A0 (en) * 1998-10-22 2001-03-31 Neurosearch As Substituted phenyl derivatives, their preparation and use.
JP4623453B2 (ja) * 1999-10-14 2011-02-02 旭化成イーマテリアルズ株式会社 アミドフェノール化合物
SI2527315T1 (sl) * 2002-05-31 2014-06-30 Proteotech Inc., Spojine, sestavki in metode za zdravljenje amiloidnih bolezni in sinukleinopatij, kot so Alzheimerjeva bolezen, diabetes tipa 2 in Parkinsonova bolezen
US7141680B2 (en) * 2002-09-20 2006-11-28 Genelabs Technologies, Inc. Aromatic compounds possessing antifungal or antibacterial activity

Also Published As

Publication number Publication date
IL179160A0 (en) 2007-03-08
AU2005245412A1 (en) 2005-12-01
EP1751097B1 (de) 2009-12-30
AU2005245412B2 (en) 2011-08-04
ES2337162T3 (es) 2010-04-21
US7745490B2 (en) 2010-06-29
EP1751097A1 (de) 2007-02-14
JP5203701B2 (ja) 2013-06-05
RU2381213C2 (ru) 2010-02-10
DE602005018634D1 (de) 2010-02-11
JP2007537287A (ja) 2007-12-20
CA2566090C (en) 2013-07-23
KR101168451B1 (ko) 2012-07-25
KR20070015612A (ko) 2007-02-05
DK1751097T3 (da) 2010-05-10
NO20065717L (no) 2007-02-08
US20060199838A1 (en) 2006-09-07
WO2005113489A1 (en) 2005-12-01
US20090060838A1 (en) 2009-03-05
BRPI0510803A (pt) 2007-11-06
CA2566090A1 (en) 2005-12-01
MXPA06012603A (es) 2007-04-12
NZ551589A (en) 2009-10-30
SG137850A1 (en) 2007-12-28
IL179160A (en) 2011-04-28
RU2006143761A (ru) 2008-06-20

Similar Documents

Publication Publication Date Title
ATE453617T1 (de) Substituierte n-arylbenzamide und verwandte verbindungen zur behandlung von amyloidkrankheiten und synukleinopathien
CY1115484T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson
UA92181C2 (ru) Производные пиримидина и их применение в терапии и в производстве лекарственного средства для предотвращения и/или лечения болезни альцгеймера
EA200901373A1 (ru) Аминогетероциклические соединения
TW200420550A (en) Thiazole compounds for the treatment of neurodegenerative disorders
GEP201706611B (en) Amido compounds and their use as pharmaceuticals
ATE416159T1 (de) Kristall für ein orales, festes arzneimittel, und ein orales, festes arnzeimittel zur behandlung von dysurie, das diesen enthält
WO2007100366A3 (en) Quinolone m1 receptor positive allosteric modulators
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
MY145647A (en) (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states)
CA2501799A1 (en) Pyrazole compounds for treatment of neurodegenerative disorders
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
EP2037739A4 (de) Benzyl-substituierte positive allosterische chinolon-m1-rezeptormodulatoren
MX2011007774A (es) Derivados de isoxazol-isoxazol e isoxazol-isotiazol.
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
MX2009014001A (es) Derivados de isoxazol-imidazol.
DK1641454T3 (da) Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere
NO20073176L (no) Nye medikamenter for behandling av luftveissykdommer
EA200701856A1 (ru) Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении
ATE399758T1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten
ATE371724T1 (de) Behandlung neurodegenerativer krankheiten
JP2021073171A (ja) （ｒ）−ジミラセタム（１）と（ｓ）−ジミラセタム（２）を非ラセミ比で含む相乗的組成物
MX2010002869A (es) Nuevos compuestos de sulfamato de uso medico.
GEP20063960B (en) New fluorinated benzothiadiazine, a process for their preparation and pharmaceutical compositions contained them
BRPI0509881A (pt) combinação terapêutica para tratamento da doença de alzheimer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1751097

Country of ref document: EP